Production (Stage)
VentriPoint Diagnostics Ltd.
VPTDF
$0.0919
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 69.70K | 100.10K | 52.80K | 33.30K | 36.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.70K | 100.10K | 52.80K | 33.30K | 36.20K |
| Cost of Revenue | -- | 0.00 | 5.00K | 5.00K | 5.00K |
| Gross Profit | 69.70K | 100.10K | 47.80K | 28.30K | 31.20K |
| SG&A Expenses | 2.87M | 3.04M | 2.89M | 2.78M | 2.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.58M | 3.77M | 3.73M | 3.54M | 3.69M |
| Operating Income | -3.51M | -3.67M | -3.68M | -3.51M | -3.65M |
| Income Before Tax | -3.65M | -3.75M | -3.70M | -3.50M | -3.61M |
| Income Tax Expenses | -59.60K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.59 | -3.75 | -3.70 | -3.50 | -3.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.59M | -3.75M | -3.70M | -3.50M | -3.61M |
| EBIT | -3.51M | -3.67M | -3.68M | -3.51M | -3.65M |
| EBITDA | -3.51M | -3.67M | -3.68M | -3.50M | -3.65M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 633.11M | 628.63M | 627.97M | 627.61M | 627.30M |
| Average Diluted Shares Outstanding | 633.11M | 628.63M | 627.97M | 627.61M | 627.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |